| Application no. and date | 11779278.8 (espacenet) (Federated) (European Patent Register), 20111014 | | Patent/reg. no. and date | DK/EP 2627319, 20181121 | | Publication date | 20130821 | | Priority no. and date | US 393103 P, 20101014 | | EP pub. no. and date |
EP 2627319 20130821 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/158089 | | Inventor | WEN, Hong, 11505 Alcinda Lane
North Potomac
Maryland 20878, US,
KUMARAPERUMAL, Natrajan, 40-B, Byrne Court
Wayne
New Jersey 07470, US,
NAUSE, Richard, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover
New Jersey 07936-1080, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/444 (2006.01) , A61K 47/20 (2006.01) , A61K 47/26 (2006.01) , A61K 47/38 (2006.01) , A61K 9/20 (2006.01) , A61K 9/28 (2006.01) | | Title | FARMACEUTISK SAMMENSÆTNINGER, DER INDEHOLDER EN DGAT1-INHIBITOR | | Int. application no. | US2011056275 | | Int. publication no. | WO2012051488 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
